'Still Bad Out There' - Drug Makers In APAC Prepare For Worst Before It Gets Better

Decoupling Forces Diversification, Evolution

 
• By Brian Yang
  
Scrip participates in commericialization panel discussion during Asia Bio Parntering Forum on April 27, 2023
AffaMed, Aum Biosciences, H3 executives discuss commercialization strategy at the Asia Bio Partnering Forum in Singapore on 27 April with moderator Brian Yang (left). • Source: EBD/Informa Connect

More from China

More from Focus On Asia